ResMed Current Ratio 2006-2019 | RMD

Current and historical current ratio for ResMed (RMD) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. ResMed current ratio for the three months ending March 31, 2019 was 2.38.
ResMed Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $1.10B $0.46B 2.38
2018-12-31 $1.06B $0.44B 2.44
2018-09-30 $1.09B $0.42B 2.58
2018-06-30 $1.07B $0.51B 2.09
2018-03-31 $1.60B $0.46B 3.48
2017-12-31 $1.75B $1.36B 1.29
2017-09-30 $1.66B $0.35B 4.72
2017-06-30 $1.64B $0.36B 4.57
2017-03-31 $1.61B $0.34B 4.77
2016-12-31 $1.52B $0.68B 2.23
2016-09-30 $1.48B $0.62B 2.38
2016-06-30 $1.42B $0.64B 2.23
2016-03-31 $1.40B $0.29B 4.89
2015-12-31 $1.35B $0.27B 5.09
2015-09-30 $1.53B $0.26B 5.96
2015-06-30 $1.41B $0.27B 5.28
2015-03-31 $1.55B $0.26B 6.06
2014-12-31 $1.56B $0.26B 6.00
2014-09-30 $1.54B $0.25B 6.04
2014-06-30 $1.56B $0.27B 5.77
2014-03-31 $1.56B $0.25B 6.33
2013-12-31 $1.56B $0.24B 6.44
2013-09-30 $1.56B $0.61B 2.55
2013-06-30 $1.45B $0.57B 2.52
2013-03-31 $1.58B $0.58B 2.72
2012-12-31 $1.53B $0.25B 6.09
2012-09-30 $1.45B $0.25B 5.73
2012-06-30 $1.36B $0.25B 5.38
2012-03-31 $1.33B $0.26B 5.15
2011-12-31 $1.25B $0.23B 5.46
2011-09-30 $1.14B $0.23B 5.06
2011-06-30 $1.29B $0.21B 6.19
2011-03-31 $1.20B $0.19B 6.28
2010-12-31 $1.15B $0.25B 4.64
2010-09-30 $1.07B $0.29B 3.73
2010-06-30 $0.99B $0.31B 3.15
2010-03-31 $1.03B $0.33B 3.17
2009-12-31 $0.93B $0.24B 3.86
2009-09-30 $0.94B $0.29B 3.22
2009-06-30 $0.85B $0.27B 3.17
2009-03-31 $0.73B $0.23B 3.19
2008-12-31 $0.71B $0.22B 3.16
2008-09-30 $0.69B $0.18B 3.90
2008-06-30 $0.74B $0.19B 3.84
2008-03-31 $0.72B $0.14B 5.06
2007-12-31 $0.69B $0.16B 4.24
2007-09-30 $0.67B $0.18B 3.71
2007-06-30 $0.67B $0.20B 3.30
2007-03-31 $0.64B $0.20B 3.18
2006-12-31 $0.59B $0.16B 3.61
2006-09-30 $0.52B $0.12B 4.27
2006-06-30 $0.51B $0.13B 3.95
2006-03-31 $0.43B $0.11B 3.91
2005-12-31 $0.40B $0.26B 1.57
2005-09-30 $0.37B $0.23B 1.61
2005-06-30 $0.36B $0.22B 1.65
2005-03-31 $0.36B $0.09B 4.22
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $16.069B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.672B 25.95
Medtronic (MDT) Ireland $117.445B 17.17
Stryker (SYK) United States $68.767B 24.54
Boston Scientific (BSX) United States $51.857B 24.86
Baxter (BAX) United States $38.426B 24.22
Zimmer Biomet Holdings (ZBH) United States $23.740B 15.25
Smith & Nephew SNATS (SNN) United Kingdom $18.286B 0.00
Canopy Growth (CGC) Canada $14.891B 0.00
Bio-Rad Laboratories (BIO) United States $8.726B 46.26
Aurora Cannabis (ACB) Canada $8.610B 84.90
Perrigo (PRGO) Ireland $6.742B 11.40
Hill-Rom Holdings (HRC) United States $6.410B 19.43
Insulet (PODD) United States $6.211B 452.52
GW Pharmaceuticals (GWPH) United Kingdom $5.395B 0.00
Haemonetics (HAE) United States $5.107B 41.90
ICU Medical (ICUI) United States $4.607B 27.49
Hutchison China MediTech (HCM) China $3.581B 0.00
NuVasive (NUVA) United States $3.197B 26.11
Neogen (NEOG) United States $3.035B 49.35
Agios Pharmaceuticals (AGIO) United States $2.854B 0.00
Quidel (QDEL) United States $2.215B 22.99
National Vision Holdings (EYE) United States $2.083B 44.38
Aphria (APHA) $1.662B 0.00
HEXO (HEXO) $1.463B 0.00
Cardiovascular Systems (CSII) United States $1.368B 785.40
Phibro Animal Health (PAHC) United States $1.179B 17.66
AtriCure (ATRC) United States $1.136B 0.00
VAREX IMAGING (VREX) United States $1.097B 23.29
NanoString Technologies (NSTG) United States $0.939B 0.00
Lantheus Holdings (LNTH) United States $0.929B 24.68
Omeros (OMER) United States $0.913B 0.00
MacroGenics (MGNX) United States $0.890B 0.00
PetIQ (PETQ) United States $0.812B 19.73
Eagle Pharmaceuticals (EGRX) United States $0.751B 21.07
Cerus (CERS) United States $0.743B 0.00
TG Therapeutics (TGTX) United States $0.594B 0.00
LeMaitre Vascular (LMAT) United States $0.534B 25.84
OraSure Technologies (OSUR) United States $0.524B 24.11
Surmodics (SRDX) United States $0.516B 74.96
Quanterix (QTRX) United States $0.500B 0.00
Meridian Bioscience (VIVO) United States $0.478B 14.62
Evolus (EOLS) United States $0.475B 0.00
BioLife Solutions (BLFS) United States $0.351B 109.94
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.314B 0.00
Utah Medical Products (UTMD) United States $0.303B 21.00
Vapotherm (VAPO) United States $0.289B 0.00
Rockwell Medical (RMTI) United States $0.282B 0.00
Zynex (ZYXI) United States $0.242B 25.07
Owens & Minor (OMI) United States $0.225B 4.76
Cytosorbents (CTSO) United States $0.223B 0.00
Bovie Medical (APYX) United States $0.206B 0.00
Chimerix (CMRX) United States $0.174B 0.00
Fonar (FONR) United States $0.135B 7.08
Chembio Diagnostics (CEMI) United States $0.132B 0.00
Surface Oncology (SURF) United States $0.110B 0.00
Female Health (VERU) United States $0.104B 0.00
InfuSystems Holdings (INFU) United States $0.098B 0.00
Neurotrope (NTRP) United States $0.092B 0.00
United-Guardian (UG) United States $0.092B 20.31
Insys Therapeutics (INSY) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 21.67
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.033B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.028B 0.00
BRAINSWAY LTD (BWAY) Israel $0.026B 0.00
Valeritas Holdings (VLRX) United States $0.022B 0.00
Myomo (MYO) United States $0.017B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 4.54